TIME (7/27, Oaklander) reports on the prospects for ketamine to be a therapy for depression. Dr. Carlos Zarate, chief of the “experimental therapeutics and pathophysiology branch at the National Institute of Mental Health and one of the foremost researchers of ketamine,” said, “It’s been a paradigm shift, that now we can achieve rapid antidepressant effects. Now we know there’s something radically different.” But, “a task force from the American Psychiatric Association (APA) concluded in an issue of the medical journal JAMA Psychiatry that ketamine wasn’t ready to be widely used as a medication for treatment-resistant depression.”

Related Links:

— “New Hope for Depression,” Mandy Oaklander, Time, July 27, 2017.

Reuters (7/26, Seaman) reports, “One suicide attempt in an army unit may foreshadow attempts by other soldiers in the same unit,” researchers concluded after analyzing “data from soldiers on active duty from 2004 through 2009.” Those data, which included “9,512 soldiers who attempted suicide during that time,” revealed that “soldiers in units with a recent suicide attempt were 40 percent more likely to attempt suicide themselves.” The findings were published online July 26 in JAMA Psychiatry.

According to Psychiatric News (7/26), the authors of an accompanying editorial wrote, “The findings from this study certainly reflect actionable information, raising tantalizing questions about the influence of military social structure and leadership on suicide risk factors as well as the potential for contagion of suicidal behaviors within Army units.” Also covering the story are HealthDay (7/26, Dotinga) and Healio (7/26, Oldt).

Related Links:

— “Suicide attempt risk in U.S. Army tied to unit’s past,” Andrew M. Seaman, Reuters, July 26, 2017.

The Washington Post (7/25, Maese) reports that investigators looking into “the link between football and chronic traumatic encephalopathy” have “found that 99 percent of the brains donated by families of former NFL players showed signs of the neurodegenerative disease.” Altogether, the investigators “examined 202 brains that belonged to men who played football at all levels and were later donated for research.” CTE was found “in 177 of them – 87 percent.” Of the brains that belonged to men who had played in the NFL, 110 of 111 were found to have CTE.

The AP (7/25, Tanner) reports, “A panel of neuropathologists made the diagnosis by examining brain tissue, using recent criteria from the National Institute of Neurological Disorders and Stroke…said” lead author Dr. Ann McKee.

TIME (7/25, Sifferlin) reports that the study indicated “the severity of CTE symptoms appeared to progress the more a person played the sport.”

The Boston Globe (7/25, Freyer) reports that “even those with mild CTE had suffered from disabling mental problems, including agitation, impulsivity, explosive tempers, and memory loss,” while “more than half contemplated suicide.”

USA Today (7/25, Perez) reports that “the most common cause of death (27%) among those with mild stages of CTE (stages 1-2) was suicide.” The findings were published July 25 in the Journal of the American Medical Association.

According to Psychiatric News (7/25), the study authors wrote, “Behavior or mood symptoms may be the initial presentation for a subset of individuals with CTE, or alternatively, CTE pathology may lower the threshold for psychiatric manifestations in susceptible individuals.”

Related Links:

— “The latest brain study examined 111 former NFL players. Only one didn’t have CTE.,” Rick Maese, Washington Post, July 25, 2017.

HealthDay (7/24, Preidt) reports that adolescents and “adults with attention-deficit/hyperactivity disorder may have a lower risk of developing an alcohol or drug problem if they take medications to treat” AD/HD, researchers concluded after examining data “from three million Americans” with AD/HD. The findings were published online June 29 in the American Journal of Psychiatry, a publication of the American Psychiatric Association.

Related Links:

— “Treating ADHD May Help Curb Later Drinking, Drug Problems,” Robert Preidt, HealthDay, July 24, 2017.

On the front of its Science Times section, the New York Times (7/24, D1, Carey, Subscription Publication) reports in a nearly 2,500-word article that “England is in the midst of a unique national experiment, the world’s most ambitious effort to treat depression, anxiety and other common mental illnesses.” The initiative “offers virtually open-ended talk therapy free of charge at clinics throughout the country,” with the goal of the eventual creation of “a system of primary care for mental health not just for England but for all of Britain.”

Related Links:

— “England’s Mental Health Experiment: No-Cost Talk Therapy,” BENEDICT CAREY, New York Times, July 24, 2017.